Chalfont, PA, United States of America

Jie Ren

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jie Ren. Retrieved from https://idiyas.com/inventor/jie-ren-sitszf8l

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0


Average Co-Inventor Count = 9.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Jie Ren in Pharmaceutical Compositions

Introduction

Jie Ren is an accomplished inventor based in Chalfont, PA (US). He holds two patents that focus on pharmaceutical compositions aimed at treating HIV infection. His work has contributed significantly to advancements in the field of medicine.

Latest Patents

Ren's latest patents include pharmaceutical compositions containing doravirine, tenofovir disoproxil fumarate, and lamivudine. These compositions are designed to be effective in the treatment of HIV infection. The patents also disclose processes for making these pharmaceutical compositions, showcasing Ren's innovative approach to addressing critical health issues.

Career Highlights

Throughout his career, Jie Ren has worked with notable companies such as Merck Sharp & Dohme Corporation and Merck Sharp & Dohme Corp. His experience in these organizations has allowed him to develop and refine his expertise in pharmaceutical innovations.

Collaborations

Ren has collaborated with talented individuals in his field, including Santipharp Panmai and Aditya Tatavarti. These partnerships have likely enhanced his research and development efforts, leading to impactful inventions.

Conclusion

Jie Ren's contributions to pharmaceutical compositions demonstrate his commitment to improving healthcare through innovation. His patents reflect a significant advancement in the treatment of HIV infection, underscoring the importance of his work in the medical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…